Bradykinin-Induced Lung Inflammation and Bronchoconstriction: Role in Parainfluenze-3 Virus-Induced Inflammation and Airway Hyperreactivity
Authors:
- 1 December 2010
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 335 (3) , 681-692
Abstract
Inhaled bradykinin causes bronchoconstriction in asthmatic subjects but not nonasthmatics. To date, animal studies with inhaled bradykinin have been performed only in anesthetized guinea pigs and rats, where it causes bronchoconstriction through sensory nerve pathways. In the present study, airway function was recorded in conscious guinea pigs by whole-body plethysmography. Inhaled bradykinin (1 mM, 20 s) caused bronchoconstriction and influx of inflammatory cells to the lungs, but only when the enzymatic breakdown of bradykinin by angiotensin-converting enzyme and neutral endopeptidase was inhibited by captopril (1 mg/kg i.p.) and phosphoramidon (10 mM, 20-min inhalation), respectively. The bronchoconstriction and cell influx were antagonized by the B2 kinin receptor antagonist 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido]-tetrahydro-2H-4-pyranylcarbonyl}piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132) when given by inhalation (1 and 10 μM, 20 min) and are therefore mediated via B2 kinin receptors. However, neither intraperitioneal MEN16132 nor the peptide B2 antagonist icatibant, by inhalation, antagonized these bradykinin responses. Sensitization of guinea pigs with ovalbumin was not sufficient to induce airway hyperreactivity (AHR) to the bronchoconstriction by inhaled bradykinin. However, ovalbumin challenge of sensitized guinea pigs caused AHR to bradykinin and histamine. Infection of guinea pigs by nasal instillation of parainfluenza-3 virus produced AHR to inhaled histamine and lung influx of inflammatory cells. These responses were attenuated by the bradykinin B2 receptor antagonist MEN16132 and H-(4-chloro)DPhe-2′(1-naphthylalanine)-(3-aminopropyl)guanidine (VA999024), an inhibitor of tissue kallikrein, the enzyme responsible for lung synthesis of bradykinin. These results suggest that bradykinin is involved in virus-induced inflammatory cell influx and AHR.Keywords
This publication has 39 references indexed in Scilit:
- MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterizationEuropean Journal of Pharmacology, 2005
- Interleukin‐4 increases murine airway response to kinins, via up‐regulation of bradykinin B1‐receptors and altered signalling along mitogen‐activated protein kinase pathwaysClinical & Experimental Allergy, 2004
- Up-Regulation of Functional Kinin B1 Receptors in Allergic Airway InflammationThe Journal of Immunology, 2002
- Species differences in bradykinin receptor-mediated responses of the airwaysAutonomic & Autacoid Pharmacology, 2002
- Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilatAmerican Journal of Physiology-Heart and Circulatory Physiology, 1996
- Allergen-induced hyperresponsiveness to bradykinin is more pronounced than that to methacholineJournal of Applied Physiology, 1995
- Elevation of Tissue Kallikrein and Kinin in the Airways of Asthmatic Subjects after Endobronchial Allergen ChallengeAmerican Review of Respiratory Disease, 1992
- Lung Peptidases, Including Carboxypeptidase, Modulate Airway Reactivity to Intravenous BradykininAmerican Review of Respiratory Disease, 1991
- Airway neutral endopeptidase-like enzyme modulates tachykinin-induced bronchoconstriction in vivoJournal of Applied Physiology, 1988
- Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects.British Journal of Clinical Pharmacology, 1983